Conflicting Roles of Molecules in Hepatocarcinogenesis: Paradigm or Paradox
- 1 February 2012
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 21 (2) , 150-154
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinomaHepatology, 2011
- Loss of Hepatocyte Growth Factor/c-Met Signaling Pathway Accelerates Early Stages of N-nitrosodiethylamine–Induced HepatocarcinogenesisCancer Research, 2007
- Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular CarcinomaCancer Cell, 2007
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences, 2006
- IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical HepatocarcinogenesisCell, 2005
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 2003
- Activation of the Met Receptor by Cell Attachment Induces and Sustains Hepatocellular Carcinomas in Transgenic MiceJournal of Cell Biology, 2001
- Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomasProceedings of the National Academy of Sciences, 1998
- N-Nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-adduct formation, mutagenicity, and tumor initiationPharmacology & Therapeutics, 1996